Fig. 1
From: Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Flow diagram for study selection
Fig. 1 | BMC Medicine
From: Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Flow diagram for study selection